Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-05 10:41 am Purchase | 2024-12-31 | 13G | Sage Therapeutics, Inc. SAGE | MORGAN STANLEY MS | 4,542,992 7.400% | 4,542,992 (New Position) | Filing History |
| 2025-01-31 09:55 am Sale | 2024-12-31 | 13G | Sage Therapeutics, Inc. SAGE | The Vanguard Group | 4,838,169 7.900% | -922,280 (-16.01%) | Filing History |
| 2025-01-17 06:02 am Sale | 2025-01-13 | 13G | Sage Therapeutics, Inc. SAGE | BB BIOTECH AG | 1,178,503 1.900% | -3,282,190 (-73.58%) | Filing History |
| 2025-01-10 5:34 pm Unchanged | 2025-01-10 | 13D | Sage Therapeutics, Inc. SAGE | BIOGEN INC. BIIB | 6,241,473 10.200% | 0 (Unchanged) | Filing History |
| 2024-11-14 6:14 pm Purchase | 2024-09-30 | 13G | Sage Therapeutics, Inc. SAGE | BB BIOTECH AG | 4,460,693 7.300% | 955,693 (+27.27%) | Filing History |
| 2024-11-12 4:56 pm Unchanged | 2024-09-30 | 13G | Sage Therapeutics, Inc. SAGE | The Vanguard Group | 5,760,449 9.430% | 0 (Unchanged) | Filing History |
| 2024-11-12 10:34 am Sale | 2024-11-08 | 13G | Sage Therapeutics, Inc. SAGE | FMR LLC | 5,271,108 8.634% | -1,031,366 (-16.36%) | Filing History |
| 2024-11-08 2:17 pm Unchanged | 2024-09-30 | 13G | Sage Therapeutics, Inc. SAGE | BlackRock Inc. BLK | 5,390,913 8.800% | 0 (Unchanged) | Filing History |
| 2024-11-04 3:28 pm Unchanged | 2024-09-30 | 13G | Sage Therapeutics, Inc. SAGE | The Vanguard Group | 5,760,449 9.430% | 0 (Unchanged) | Filing History |
| 2024-11-04 2:10 pm Sale | 2024-09-30 | 13G | Sage Therapeutics, Inc. SAGE | The Vanguard Group | 5,760,449 9.430% | -542,098 (-8.60%) | Filing History |
| 2024-10-21 4:11 pm Purchase | 2024-09-30 | 13G | Sage Therapeutics, Inc. SAGE | BlackRock Inc. BLK | 5,390,913 8.800% | 727,013 (+15.59%) | Filing History |
| 2024-10-18 11:37 am Sale | 2024-09-30 | 13G | Sage Therapeutics, Inc. SAGE | STATE STREET CORP STT | 2,926,239 4.800% | -991,983 (-25.32%) | Filing History |
| 2024-06-10 12:15 pm Purchase | 2024-05-31 | 13G | Sage Therapeutics, Inc. SAGE | The Vanguard Group | 6,302,547 10.470% | 983,187 (+18.48%) | Filing History |
| 2024-06-10 09:48 am Purchase | 2024-06-07 | 13G | Sage Therapeutics, Inc. SAGE | FMR LLC | 6,302,474 10.472% | 819,997 (+14.96%) | Filing History |
| 2024-06-06 09:54 am Sale | 2024-05-31 | 13G | Sage Therapeutics, Inc. SAGE | Wellington Management Group LLP | 39,757 0.070% | -6,022,239 (-99.34%) | Filing History |
| 2024-02-14 07:09 am Purchase | 2023-12-31 | 13G | Sage Therapeutics, Inc. SAGE | RTW INVESTMENTS LP | 5,197,019 8.700% | 5,197,019 (New Position) | Filing History |
| 2024-02-13 5:13 pm Purchase | 2023-12-29 | 13G | Sage Therapeutics, Inc. SAGE | The Vanguard Group | 5,319,360 8.860% | 433,808 (+8.88%) | Filing History |
| 2024-02-13 06:28 am Purchase | 2023-12-31 | 13G | Sage Therapeutics, Inc. SAGE | BB BIOTECH AG | 3,505,000 5.800% | 404,722 (+13.05%) | Filing History |
| 2024-02-09 09:49 am Sale | 2024-02-08 | 13G | Sage Therapeutics, Inc. SAGE | FMR LLC | 5,482,477 9.132% | -1,069,013 (-16.32%) | Filing History |
| 2024-02-08 10:17 am Sale | 2023-12-29 | 13G | Sage Therapeutics, Inc. SAGE | Wellington Management Group LLP | 6,061,996 10.100% | -301,634 (-4.74%) | Filing History |